Terminated OBSERVATIONAL NCT04912180

Apple Respiratory Study (ARS)

Apple Respiratory Study: A Prospective Study of Apple Watch-based Detection of Respiratory Viral Illness in Greater Seattle, WA

Sponsor: Apple Inc.

Conditions Acute Respiratory Infection Coronavirus Infection Influenza

Updated 3 times since 2021 Last updated: Jul 12, 2021 Started: Apr 6, 2021 Primary completion: Jun 9, 2021 Completion: Jun 9, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study endpoints no longer feasible.

Other terminated trials from Apple Inc.

More terminations from Apple Inc.

A observational or N/A phase clinical study on Acute Respiratory Infection and Coronavirus Infection, this trial is terminated or withdrawn. The trial is conducted by Apple Inc. and has accumulated 3 data snapshots since 2021. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Sep 2021 — Jul 2024 [monthly]

Terminated

First recorded

Apr 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Apple Inc.
University of Washington

Data source: Apple Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seattle, United States